{"id":"https://openalex.org/W11047152","doi":null,"title":"High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer.","display_name":"High-dose therapy with carboplatin and paclitaxel in non-small cell lung cancer.","publication_year":1997,"publication_date":"1997-08-01","ids":{"openalex":"https://openalex.org/W11047152","mag":"11047152","pmid":"https://pubmed.ncbi.nlm.nih.gov/9331121"},"language":"en","primary_location":{"id":"pmid:9331121","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9331121","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M A Socinski","raw_affiliation_strings":["Multidisciplinary Thoracic Oncology Program, Department of Medicine, University of North Carolina at Chapel Hill, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multidisciplinary Thoracic Oncology Program, Department of Medicine, University of North Carolina at Chapel Hill, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103737363","display_name":"Thomas C. Shea","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T C Shea","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.7347,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.71109505,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"24","issue":"4 Suppl 12","first_page":"S12","last_page":"45"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.8812999725341797,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.10989999771118164,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":0.8679999709129333},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.6800000071525574},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.7440000176429749},{"id":"https://openalex.org/keywords/peripheral-blood-stem-cell-support","display_name":"peripheral blood stem cell support","score":0.7059999704360962},{"id":"https://openalex.org/keywords/filgrastim","display_name":"filgrastim","score":0.9879999756813049},{"id":"https://openalex.org/keywords/locally-advanced-nsclc","display_name":"locally advanced non-small cell lung cancer","score":0.7269999980926514},{"id":"https://openalex.org/keywords/induction-therapy","display_name":"induction therapy","score":0.4830000102519989},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.4519999921321869}],"concepts":[{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.9336254596710205},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9231935739517212},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.6223156452178955},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.617442786693573},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.6170881986618042},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6157615780830383},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6110885143280029},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5523767471313477},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.49094727635383606},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.41140276193618774},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4044463634490967},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3210066854953766},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069585","descriptor_name":"Filgrastim","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003131","descriptor_name":"Combined Modality Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000532","qualifier_name":"radiotherapy","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016190","descriptor_name":"Carboplatin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D018380","descriptor_name":"Hematopoietic Stem Cell Transplantation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:9331121","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9331121","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},{"id":"mag:11047152","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9331121","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2158513591","https://openalex.org/W1976994785","https://openalex.org/W126474683","https://openalex.org/W47947159","https://openalex.org/W51336411","https://openalex.org/W2402700221","https://openalex.org/W1894984004","https://openalex.org/W2444179130","https://openalex.org/W2369095521","https://openalex.org/W2418146115"],"abstract_inverted_index":{"Non-small":[0],"cell":[1],"lung":[2],"cancer":[3,10],"(NSCLC)":[4],"remains":[5],"the":[6,13,49,64,72,96,110,136,152,216,279,300],"leading":[7],"cause":[8],"of":[9,18,51,66,74,98,112,129,141,154,160,166,172,188,194,226,242,281,302],"deaths":[11],"in":[12,63,101,151,164,209,285,305],"United":[14],"States.":[15],"The":[16,45,157,168],"combination":[17],"more":[19],"active":[20],"agents":[21,76],"like":[22],"vinorelbine":[23],"and":[24,59,149,218,250,275,278],"paclitaxel":[25,119,176,230],"(Taxol;":[26],"Bristol-Myers":[27],"Squibb":[28],"Company,":[29],"Princeton,":[30],"NJ)":[31],"with":[32,41,68,77,175,197,211,229,287],"cisplatin":[33],"has":[34],"led":[35],"to":[36,47,94,117,255,298],"improved":[37],"survival":[38],"for":[39,87],"patients":[40,67,196,210,222,258,286],"advanced":[42,69,155,198,213,289],"metastatic":[43],"disease.":[44],"ability":[46],"escalate":[48],"dose":[50,140,159,171],"cisplatin-based":[52],"regimens":[53],"is":[54,60,205],"limited":[55],"by":[56,144,215,237,245],"nonhematologic":[57],"toxicities":[58],"especially":[61],"difficult":[62],"population":[65],"NSCLC.":[70,156,290,306],"However,":[71],"development":[73],"new":[75,85],"significant":[78],"activity":[79],"against":[80],"NSCLC":[81,199,214],"as":[82,84],"well":[83],"strategies":[86],"high-dose":[88,283],"therapy":[89,100,228],"have":[90],"made":[91],"it":[92],"possible":[93],"examine":[95,273],"potential":[97],"dose-intense":[99],"this":[102,191,282,303],"population.":[103],"A":[104],"phase":[105,269,292],"I":[106],"trial":[107,271],"performed":[108],"at":[109,132,185,239],"University":[111],"North":[113],"Carolina":[114],"was":[115,162,183],"designed":[116],"evaluate":[118],"250":[120,177,231],"mg/m2":[121,178,232],"given":[122],"over":[123,180,233],"24":[124,181],"hours":[125,182,235],"plus":[126],"escalating":[127],"doses":[128],"carboplatin":[130,161,173,238],"starting":[131],"an":[133,186,240],"area":[134],"under":[135],"concentration-time":[137],"curve":[138],"(AUC)":[139],"8":[142],"supported":[143,244],"peripheral":[145,246],"blood":[146,247],"stem":[147,248],"cells":[148,249],"filgrastim":[150],"treatment":[153],"AUC":[158,187,241],"escalated":[163],"increments":[165],"2.":[167],"maximum":[169],"tolerated":[170],"combined":[174],"administered":[179],"defined":[184],"18.":[189],"In":[190],"study,":[192],"six":[193],"seven":[195],"had":[200],"major":[201],"responses.":[202],"This":[203,268],"regimen":[204,284],"currently":[206],"being":[207],"tested":[208],"locally":[212,288],"Cancer":[217],"Leukemia":[219],"Group":[220],"B:":[221],"receive":[223,260],"two":[224],"cycles":[225],"induction":[227,256],"3":[234],"followed":[236],"18":[243],"filgrastim.":[251],"Depending":[252],"on":[253],"response":[254],"therapy,":[257,265],"then":[259],"surgical":[261],"resection,":[262],"thoracic":[263],"radiation":[264],"or":[266],"both.":[267],"II":[270],"will":[272,295],"clinical":[274],"pathologic":[276],"responses":[277],"toxicity":[280],"Ultimately,":[291],"III":[293],"trials":[294],"be":[296],"needed":[297],"establish":[299],"role":[301],"approach":[304]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}